Patents by Inventor Grasiela Bourscheit Willmbrink

Grasiela Bourscheit Willmbrink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PARENTERAL FORMULATIONS AND USES THEREOF
    Publication number: 20240091221
    Abstract: This invention relates generally to therapeutic parenteral formulations comprising particular substituted pyridine based compounds, their manufacture, and methods and uses of said formulations in treating elevated intracranial pressure for indications such as, but not limited to, traumatic brain injury and stroke.
    Type: Application
    Filed: September 26, 2023
    Publication date: March 21, 2024
    Applicant: Eustralis Pharmaceuticals Limited (Trading as Pressura Neuro)
    Inventors: Pierre VANKAN, Andreea SASARMAN, Grasiela Bourscheit WILLMBRINK
  • Parenteral formulations and uses thereof
    Patent number: 11801244
    Abstract: This invention relates generally to therapeutic parenteral formulations comprising particular substituted pyridine based compounds, their manufacture, and methods and uses of said formulations in treating elevated intracranial pressure for indications such as, but not limited to, traumatic brain injury and stroke.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: October 31, 2023
    Assignee: Eustralis Pharmaceuticals Limited
    Inventors: Pierre Vankan, Andreea Sasarman, Grasiela Bourscheit Willmbrink
  • Parenteral Formulations And Uses Thereof
    Publication number: 20200368226
    Abstract: This invention relates generally to therapeutic parenteral formulations comprising particular substituted pyridine based compounds, their manufacture, and methods and uses of said formulations in treating elevated intracranial pressure for indications such as, but not limited to, traumatic brain injury and stroke.
    Type: Application
    Filed: February 1, 2019
    Publication date: November 26, 2020
    Applicant: Eustralis Pharmaceuticals Limited (Trading As Pressura Neuro)
    Inventors: Pierre Vankan, Andreea Sasarman, Grasiela Bourscheit Willmbrink
  • Oral Formulations And Uses Thereof
    Publication number: 20200368166
    Abstract: Disclosed are therapeutic oral formulations comprising particular substituted pyridine based compounds, their manufacture, and methods and uses of the formulations in treating substance P mediated pathways in the brain such as elevated intracranial pressure or the modification of expression of (hyper)-phosphorylated tau protein (?) in the brain for indications such as, but not limited to concussion, post-concussive (or post-concussion) syndrome (PCS), chronic traumatic encephalopathy (CTE), traumatic brain injury (TBI) and stroke.
    Type: Application
    Filed: February 1, 2019
    Publication date: November 26, 2020
    Applicant: Eustralis Pharmaceuticals Limited (Trading As Pressura Neuro)
    Inventors: Pierre Vankan, Andreea Sasarman, Grasiela Bourscheit Willmbrink